A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 214,974 shares of DXCM stock, worth $16.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
214,974
Previous 217,359 1.1%
Holding current value
$16.1 Million
Previous $24.6 Million 41.54%
% of portfolio
0.04%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $152,640 - $276,803
-2,385 Reduced 1.1%
214,974 $14.4 Million
Q2 2024

Jul 22, 2024

BUY
$110.31 - $140.45 $416,199 - $529,917
3,773 Added 1.77%
217,359 $24.6 Million
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $256,309 - $314,384
-2,244 Reduced 1.04%
213,586 $29.6 Million
Q4 2023

Jan 24, 2024

SELL
$75.49 - $124.16 $165,700 - $272,531
-2,195 Reduced 1.01%
215,830 $26.8 Million
Q3 2023

Oct 23, 2023

SELL
$86.06 - $137.93 $428,148 - $686,201
-4,975 Reduced 2.23%
218,025 $20.3 Million
Q2 2023

Jul 25, 2023

SELL
$112.47 - $130.98 $174,665 - $203,411
-1,553 Reduced 0.69%
223,000 $28.7 Million
Q1 2023

May 17, 2023

BUY
$104.0 - $122.92 $22.6 Million - $26.8 Million
217,643 Added 3149.68%
224,553 $26.1 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $22.4 Million - $26.5 Million
-215,286 Reduced 96.89%
6,910 $803 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $1.49 Million - $2.15 Million
-17,549 Reduced 7.32%
222,196 $25.2 Million
Q3 2022

Nov 04, 2022

BUY
$76.35 - $94.18 $206,832 - $255,133
2,709 Added 1.14%
239,745 $19.3 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $12.2 Million - $23.8 Million
178,762 Added 306.76%
237,036 $17.7 Million
Q1 2022

Apr 27, 2022

BUY
$94.08 - $130.2 $13,829 - $19,139
147 Added 0.25%
58,274 $29.8 Million
Q4 2021

Jan 31, 2022

SELL
$129.87 - $162.82 $165,584 - $207,595
-1,275 Reduced 2.15%
58,127 $31.2 Million
Q3 2021

Oct 20, 2021

SELL
$106.71 - $143.18 $237,002 - $318,002
-2,221 Reduced 3.6%
59,402 $32.5 Million
Q2 2021

Jul 20, 2021

SELL
$80.99 - $107.93 $236,895 - $315,695
-2,925 Reduced 4.53%
61,623 $26.3 Million
Q1 2021

Apr 22, 2021

SELL
$84.79 - $104.74 $388,083 - $479,394
-4,577 Reduced 6.62%
64,548 $23.2 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $145,626 - $195,101
-1,867 Reduced 2.63%
69,125 $25.6 Million
Q3 2020

Nov 06, 2020

SELL
$95.51 - $112.95 $313,272 - $370,476
-3,280 Reduced 4.42%
70,992 $29.3 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $4.66 Million - $7.82 Million
74,272 New
74,272 $30.1 Million
Q3 2018

Oct 23, 2018

SELL
$23.35 - $36.72 $663,770 - $1.04 Million
-28,427 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$17.54 - $25.22 $305,599 - $439,408
-17,423 Reduced 38.0%
28,427 $2.7 Million
Q1 2018

Apr 10, 2018

SELL
$13.06 - $18.54 $14,300 - $20,301
-1,095 Reduced 2.33%
45,850 $3.4 Million
Q4 2017

Jan 22, 2018

SELL
$11.12 - $15.38 $7,116 - $9,843
-640 Reduced 1.34%
46,945 $2.69 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $540,565 - $903,163
47,585
47,585 $2.33 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.